Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / COM
-
Shares outstanding
-
40.8M
-
Number of holders
-
118
-
Total 13F shares, excl. options
-
31.6M
-
Shares change
-
+5.83M
-
Total reported value, excl. options
-
$1.14B
-
Value change
-
+$204M
-
Put/Call ratio
-
0.15
-
Number of buys
-
75
-
Number of sells
-
-36
-
Price
-
$35.98
Significant Holders of Pulmonx Corp - COM (LUNG) as of Q3 2021
136 filings reported holding LUNG - Pulmonx Corp - COM as of Q3 2021.
Pulmonx Corp - COM (LUNG) has 118 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 31.6M shares
of 40.8M outstanding shares and own 77.52% of the company stock.
Largest 10 shareholders include PRIMECAP MANAGEMENT CO/CA/ (2.97M shares), Capital World Investors (2.75M shares), BlackRock Inc. (2.74M shares), VANGUARD GROUP INC (2.45M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (2.03M shares), Champlain Investment Partners, LLC (1.8M shares), TimesSquare Capital Management, LLC (1.27M shares), RTW INVESTMENTS, LP (1.16M shares), Miura Global Management, LLC (1.06M shares), and GILDER GAGNON HOWE & CO LLC (1.01M shares).
This table shows the top 118 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.